Cefepime compound antibacterial drugs

A cefepime and drug technology, applied in the field of fourth-generation cephalosporin antibiotics, can solve the problems of insensitivity to β-lactamase-producing bacteria and poor efficacy

Inactive Publication Date: 2005-01-19
张哲峰
View PDF0 Cites 27 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to provide a drug with a wider antibacterial spectrum and stronger antibacterial effect for the defects that the existing sin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0022] Example 1: Under aseptic and clean conditions, 10 kg of cefepime internal salt and 5 kg of potassium clavulanate (calculated as free acid) were mixed, and the powder injection preparation process was followed to prepare 10,000 powder injections of the present invention.

Example Embodiment

[0023] Example 2: Under aseptic and clean conditions, 10 kg of cefepime hydrochloride (calculated as cefepime) and 20 kg of potassium clavulanate (calculated as free acid) were mixed, followed by the preparation process of powder injection to prepare the Invented 10,000 powder injections.

Example Embodiment

[0024] Example 3: Under aseptic and clean conditions, mix 10 kg of cefepime (calculated as cefepime), 1 kg of clavulanate potassium (calculated as free acid) and 7.25 kg of L-arginine, and freeze-dry The powder injection preparation process is operated to prepare 10,000 powder injections of the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a cefepime antibacterial drug comprising cefepime and beta-lactam enzyme inhibitor by the ratio by weight of 1:2 to 1:0.1, wherein the cefepime is cefepime inner salt, or cefepime hydrochlorate, or cefepime hydrochlorate hydrate, or one of the former medicaments with added adjunct (L-arginine, or sodium carbonate, or sodium hydrogen carbonate, the beta-lactam enzyme inhibitor can be Tazobactam, or clavulanic acid, or tapazole or their derivatives.

Description

technical field [0001] The invention relates to fourth-generation cephalosporin antibiotics, namely a cefepime (Cefepime) antibacterial combination drug. Background technique [0002] The antibacterial activity of the fourth-generation cephalosporin antibiotic Cefepime (Cefepime) is similar to that of the third-generation cephalosporin antibiotic, but the antibacterial spectrum has been further expanded, and it is effective against G+ bacteria including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, saprophytic bacteria Staphylococcus, Streptococcus pneumoniae (including penicillin-resistant strains with penicillin MIC of 0.1-1.0 μg / ml) and other hemolytic streptococci have obvious antibacterial effects; G-bacteria include Pseudomonas, Escherichia coli, Klebsiella, Enterobacter, Proteus, Acinetobacter calcoacetate, Aeromonas hydrophila, Capnocytophaga, Citrobacter, Campylobacter jejuni, Gardnerella vaginalis, Haemophilus, Nai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/545A61P31/04
Inventor 张哲峰
Owner 张哲峰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap